Study looks at safety, effectiveness of generics for treating depression
Researchers at the School of Medicine are studying the quality, effectiveness and safety of generic drugs used to treat depression. The research, supported by the U.S. Food and Drug Administration, is the only study of its kind in the nation. Pictured is the study’s principal investigator, Evan D. Kharasch, MD, PhD.
Kharasch, Sadler elected to Institute of Medicine
The School of Medicine’s Evan D. Kharasch, MD, PhD (left) and J. Evan Sadler, MD, PhD, have been elected to the Institute of Medicine of the National
Academy of Sciences, one of the highest honors medical scientists in the United States can receive.
University will anchor new CORTEX building
Washington University will be the anchor tenant in a $73 million laboratory and research facility projected to open at the end of the year in the CORTEX bioscience district. Pictured is Hank Webber, executive vice chancellor for administration, who described the University’s role in the new building at a recent event there.